600513 Jiangsu Lianhuan Pharmaceutical
- 8.57
- +0.27+3.25%
Jiangsu Lianhuan Pharmaceutical News
Announcement on the progress of jiangsu lianhuan pharmaceutical's controlling shareholder's shareholding of the company's shares and subsequent shareholding plan as well as the action plan of "improving quality and efficiency and returning reward".
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's announcement on terminating the issuance of convertible corporate bonds to unspecified recipients.
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's plan to issue stocks to specific targets through a simplified process in 2024.
Jiangsu Lianhuan Pharmaceutical: Announcement on the Regulatory Measures, Punishments, and Rectifications taken by Securities Regulatory Authorities and Exchanges in the past five years regarding Jiangsu Lianhuan Pharmaceutical
Jiangsu Lianhuan Pharmaceutical: Shareholder dividend return plan for the next three years (2024-2026) of Jiangsu Lianhuan Pharmaceutical.
Jiangsu Lianhuan Pharmaceutical: Feasibility analysis report for the use of funds raised through the issuance of stocks to specific objects in easy procedures by Jiangsu Lianhuan Pharmaceutical in 2024.
Jiangsu Lianhuan Pharmaceutical: Announcement on the Resolution of the Second Extraordinary Meeting of the Ninth Supervisory Board of Jiangsu Lianhuan Pharmaceutical
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's announcement regarding the preliminary proposal to issue stocks to specific individuals through a simplified procedure for the 2024 fiscal year.
Jiangsu Lianhuan Pharmaceutical: Announcement from Jiangsu Lianhuan Pharmaceutical regarding the risk warning and mitigation measures, as well as relevant commitments from specific parties, for the dilutive immediate return of stocks issued to specific targets via simplified procedures in 2024.
Jiangsu Lianhuan Pharmaceutical: Announcement from Jiangsu Lianhuan Pharmaceutical regarding exemption of compiling report on the use of previous fundraising.
Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's analysis report on the proposal for issuing stocks to specific targets through simplified procedures in 2024.
Jiangsu Lianhuan Pharmaceutical: Announcement of the Resolution of the Second Interim Meeting of the Ninth Board of Directors of Jiangsu Lianhuan Pharmaceutical.
Announcement of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Obtaining the Pharmaceutical Registration Certificate.
Announcement of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Obtaining the Pharmaceutical Registration Certificate.
Jiangsu Lianhuan Pharmaceutical's announcement regarding the approval of the application for the listing of chemical raw materials as active pharmaceutical ingredients.
Announcement of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Obtaining the Pharmaceutical Registration Certificate.
Lianhuan Pharmaceutical's 2023 Annual Equity Distribution Implementation Notice
Lianhuan Pharmaceutical Report for the First Quarter of 2024
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Lianhuan Pharmaceutical
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on Lianhuan Pharmaceutical's 2024 First Extraordinary General Meeting of Shareholders
Analysis
Price Target
No Data
